FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> FDA   Pfizer   pharmaceuticals   Phase III
Syndicate content

sales and marketing News

Most Popular sales and marketing Story

WuXi buyout deal raises questions on scientists' pay scale

The average scientist on WuXi PharmaTech's Chinese payroll earns about $30,000 a year, roughly equivalent to 10 percent of what it costs to emply an American researcher with the same qualifications. Read more...

Latest Headlines